SE

Sakshi Eknath Dhas

Active Director Designated Partner DIN 11720465
DIN 11720465 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sakshi Eknath Dhas

Data last updated:

Sakshi Eknath Dhas is a Designated Partner at Swarsiddhi Pharmaceuticals Llp (since 2026).

DIN 11720465
Primary Designation Designated Partner
First Appointment 15 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 May 20262026Active

Board colleagues of Sakshi Eknath Dhas

Directorship timeline

Open interactive timeline →
Swarsiddhi Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Sakshi Eknath Dhas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sakshi Eknath Dhas

Sakshi Eknath Dhas currently holds 1 directorship: Swarsiddhi Pharmaceuticals Llp (Designated Partner, since 15 May 2026).

Sakshi Eknath Dhas was first appointed on 15 May 2026 as Designated Partner at Swarsiddhi Pharmaceuticals Llp.

The current boards of Sakshi Eknath Dhas's companies include Aarti Eknath Dhas (Swarsiddhi Pharmaceuticals Llp), Gitanjali Rahul Dhas (Swarsiddhi Pharmaceuticals Llp), Kiran Purushottam Dhas (Swarsiddhi Pharmaceuticals Llp), Rahul Purushottam Dhas (Swarsiddhi Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available